Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAPDH | P04406 | 1/20 | 0.36 |
| ▸ | MPI | P34949 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16600348 | 1.00 | GAPDH (0.36) | GAPDHMPIAKR1B1TSHRSMN1; SMN2 | |
| SCHEMBL6886342 | 0.92 | GAPDH (0.34) | GAPDHMPIAKR1B1TSHRSMN1; SMN2 | |
| SCHEMBL13447579 | 0.92 | GAPDH (0.34) | GAPDHMPIAKR1B1TSHRSMN1; SMN2 | |
| SCHEMBL16488196 | 0.92 | GAPDH (0.34) | GAPDHMPIAKR1B1TSHRSMN1; SMN2 | |
| SCHEMBL15798110 | 0.92 | GAPDH (0.34) | GAPDHMPIAKR1B1TSHRSMN1; SMN2 | |
| SCHEMBL12418550 | 0.92 | GAPDH (0.34) | GAPDHMPIAKR1B1TSHRSMN1; SMN2 | |
| SCHEMBL28339104 | 0.90 | MPI (0.33) | GAPDHMPI | |
| SCHEMBL16600199 | 0.83 | — | — | |
| SCHEMBL13758783 | 0.83 | — | — | |
| SCHEMBL31984 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9975911-B2 | Antibacterial compounds and biological applications thereof | MUTABILIS (FR) | 2018-05-22 | — | — | US | disclosed |
| US-20150291636-A1 | ANTIBACTERIAL COMPOUNDS AND BIOLOGICAL APPLICATIONS THEREOF | LABORATOIRE BIODIM (FR) | 2015-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291636-A1 | ANTIBACTERIAL COMPOUNDS AND BIOLOGICAL APPLICATIONS THEREOF | C3AR1, CFH, MSR1 | GAPDH 2505/4885MPI 2631/4885AKR1B1 413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.